期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 34, 期 4, 页码 887-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2020.06.002
关键词
Aminoglycosides; 16S rRNA methyltransferases; Gram-negative bacteria; Plazomicin
资金
- Japan Society for the Promotion of Science
- National Institutes of Health [R01AI104895, R21AI135522]
Aminoglycoside-resistant gram-negative pathogens producing 16S ribosomal RNA (rRNA) methyltransferase (MTase) have emerged and spread globally. 16S rRNA MTase-producing gram-negative pathogens tend to show a multidrugresistance profile against b-lactams and fluoroquinolones. 16S rRNA MTase producers resist the newly approved aminoglycoside, plazomicin. Treatment options are limited for infections caused by multidrug-resistant 16S rRNA MTase producers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
